This study is testing a new medicine called **volixibat** to help with itching (pruritus) caused by a liver disease called **Primary Biliary Cholangitis (PBC)**. PBC is a condition where the bile ducts in the liver get damaged, leading to liver problems and itching. This study wants to see if volixibat can help reduce the itching and slow down the progression of PBC.
Eligibility: To join, you must be 18 years or older, have a confirmed PBC diagnosis, and agree to attend all study visits. People with itching not caused by PBC or with certain other liver issues can’t join.
- Length of Study: Participants will be involved for the entire study duration, attending all required visits.
- Compensation: Participants may receive compensation for their time and travel.
- Risks: As with any study, there may be risks, and it's important to discuss these with your doctor.
If you think you might be eligible and want to help researchers learn more about treating itching in PBC, talk to your doctor about joining this study.